ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
kpax
|
77 |
26K |
28 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
77
|
26K
|
28
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
kpax
|
157 |
38K |
3 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
157
|
38K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
kpax
|
157 |
38K |
18 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
157
|
38K
|
18
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
68 |
19K |
21 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
68
|
19K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Granted SME Status by European Medicines Agency
|
|
kpax
|
15 |
5.9K |
36 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
15
|
5.9K
|
36
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
68 |
19K |
13 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
68
|
19K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
kpax
|
77 |
26K |
32 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
77
|
26K
|
32
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
68 |
19K |
15 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
68
|
19K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
kpax
|
209 |
55K |
41 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
209
|
55K
|
41
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
kpax
|
940 |
246K |
14 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
940
|
246K
|
14
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
68 |
19K |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
68
|
19K
|
14
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
68 |
19K |
14 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
68
|
19K
|
14
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
68 |
19K |
14 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
68
|
19K
|
14
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
kpax
|
40 |
12K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
40
|
12K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
kpax
|
40 |
12K |
4 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
40
|
12K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
kpax
|
940 |
246K |
53 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
940
|
246K
|
53
|
|
ASX - By Stock
|
SNT |
Syntara the science explained
|
|
kpax
|
68 |
19K |
27 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
68
|
19K
|
27
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
kpax
|
40 |
12K |
6 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
12K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
kpax
|
40 |
12K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
12K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
kpax
|
940 |
246K |
11 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
940
|
246K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
|
|
kpax
|
43 |
12K |
36 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
43
|
12K
|
36
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
kpax
|
250 |
65K |
14 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
250
|
65K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
kpax
|
250 |
65K |
15 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
250
|
65K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
kpax
|
250 |
65K |
12 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
250
|
65K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
kpax
|
83 |
24K |
37 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
83
|
24K
|
37
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
kpax
|
239 |
66K |
17 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
66K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
kpax
|
239 |
66K |
14 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
66K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
kpax
|
239 |
66K |
37 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
66K
|
37
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
kpax
|
239 |
66K |
30 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
239
|
66K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
kpax
|
104 |
21K |
16 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
104
|
21K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
kpax
|
104 |
21K |
25 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
104
|
21K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
371K |
24 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.4K
|
371K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
kpax
|
104 |
21K |
47 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
21K
|
47
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
371K |
19 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.4K
|
371K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
371K |
51 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
371K
|
51
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
kpax
|
1 |
1.0K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
1
|
1.0K
|
4
|
|
ASX - By Stock
|
PAA |
NZT gone but hasn't forgotten
|
|
kpax
|
66 |
19K |
62 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
66
|
19K
|
62
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
kpax
|
126 |
33K |
20 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
126
|
33K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
kpax
|
126 |
33K |
22 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
33K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
kpax
|
126 |
33K |
28 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
33K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
kpax
|
317 |
84K |
26 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
317
|
84K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
kpax
|
100 |
29K |
21 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
29K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
371K |
22 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
1.4K
|
371K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
kpax
|
58 |
16K |
23 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
58
|
16K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
kpax
|
58 |
16K |
32 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
58
|
16K
|
32
|
|
ASX - By Stock
|
PAA |
Amylyx class action Relyvrio
|
|
kpax
|
58 |
16K |
36 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
58
|
16K
|
36
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
371K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1.4K
|
371K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
371K |
20 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1.4K
|
371K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
371K |
15 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.4K
|
371K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
kpax
|
114 |
34K |
18 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
34K
|
18
|
|